Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital

BACKGROUND AND AIM: Comirnaty® was the first COVID-19 vaccine available for the vaccination campaign of healthcare workers in Italy. With the aim of assessing vaccine safety, we conducted a cross-sectional survey administrating a voluntary-based questionnaire on adverse events following immunisation...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigezzi, Giacomo Pietro, Lume, Alessandra, Minerva, Massimo, Nizzero, Paola, Biancardi, Anna, Gianfredi, Vincenza, Odone, Anna, Signorelli, Carlo, Moro, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Original Investigations/Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851005/
https://www.ncbi.nlm.nih.gov/pubmed/34739472
http://dx.doi.org/10.23750/abm.v92iS6.12217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851005/
https://www.ncbi.nlm.nih.gov/pubmed/34739472
http://dx.doi.org/10.23750/abm.v92iS6.12217

Ejemplares similares